Parsec Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $8.16M | Buy |
9,928
+21
| +0.2% | +$17.3K | 0.34% | 70 |
|
|
2022
Q4 | $7.15M | Buy |
9,907
+415
| +4% | +$299K | 0.32% | 73 |
|
|
2022
Q3 | $6.54M | Buy |
9,492
+383
| +4% | +$264K | 0.33% | 69 |
|
|
2022
Q2 | $5.39M | Buy |
9,109
+375
| +4% | +$222K | 0.26% | 75 |
|
|
2022
Q1 | $6.1M | Buy |
8,734
+656
| +8% | +$458K | 0.26% | 73 |
|
|
2021
Q4 | $5.1M | Buy |
8,078
+254
| +3% | +$160K | 0.21% | 79 |
|
|
2021
Q3 | $4.82M | Buy |
7,824
+978
| +14% | +$603K | 0.21% | 80 |
|
|
2021
Q2 | $3.82M | Buy |
6,846
+522
| +8% | +$292K | 0.18% | 89 |
|
|
2021
Q1 | $2.99M | Buy |
6,324
+794
| +14% | +$376K | 0.15% | 102 |
|
|
2020
Q4 | $2.67M | Buy |
5,530
+29
| +0.5% | +$14K | 0.14% | 104 |
|
|
2020
Q3 | $3.08M | Sell |
5,501
-273
| -5% | -$153K | 0.19% | 89 |
|
|
2020
Q2 | $3.6M | Sell |
5,774
-542
| -9% | -$338K | 0.23% | 83 |
|
|
2020
Q1 | $3.08M | Sell |
6,316
-1,215
| -16% | -$593K | 0.23% | 88 |
|
|
2019
Q4 | $2.83M | Sell |
7,531
-3,545
| -32% | -$1.33M | 0.17% | 101 |
|
|
2019
Q3 | $3.07M | Sell |
11,076
-4,518
| -29% | -$1.25M | 0.19% | 97 |
|
|
2019
Q2 | $4.88M | Buy |
15,594
+7,375
| +90% | +$2.31M | 0.3% | 80 |
|
|
2019
Q1 | $3.38M | Buy |
8,219
+5,830
| +244% | +$2.39M | 0.21% | 96 |
|
|
2018
Q4 | $892K | Buy |
+2,389
| New | +$892K | 0.06% | 144 |
|